Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations
Clinical trial NCT03404817 · COMPLETED
Trial details
- NCT number
- NCT03404817
- Sponsor
- Embera NeuroTherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-06-07
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.